scispace - formally typeset
P

Paul Anthony Scuffham

Researcher at Griffith University

Publications -  418
Citations -  11718

Paul Anthony Scuffham is an academic researcher from Griffith University. The author has contributed to research in topics: Health care & Cost effectiveness. The author has an hindex of 53, co-authored 395 publications receiving 9998 citations. Previous affiliations of Paul Anthony Scuffham include University of York & University of Otago.

Papers
More filters
Journal ArticleDOI

The Health Care Costs of Diabetic Peripheral Neuropathy in the U.S.

TL;DR: The annual medical costs of diabetic peripheral neuropathy and its complications among people with type 1 and type 2 diabetes in the U.S. was estimated to be between $4.6 and $13.7 billion, up to 27% of the direct medical cost of diabetes.
Journal ArticleDOI

Incidence and costs of unintentional falls in older people in the United Kingdom

TL;DR: Unintentional falls impose a substantial burden on health and social services and cost the UK government £981 million in the 60–64 age group, increasing to £1 500 000 in the ⩾75 age group.
Journal ArticleDOI

Socioeconomic disparities in prepregnancy BMI and impact on maternal and neonatal outcomes and postpartum weight retention: the EFHL longitudinal birth cohort study

TL;DR: Findings provide additional specificity to the increasing evidence of the predisposition of obesity prepregnancy on adverse maternal and perinatal outcomes and may be used to target effective behavioural change interventions to address obesity in women.
Journal ArticleDOI

Negative pressure wound therapy for skin grafts and surgical wounds healing by primary intention

TL;DR: Evidence for the effects of negative pressure wound therapy (NPWT) for reducing SSI and wound dehiscence remains unclear, as does the effect of NPWT on time to complete healing.
Journal ArticleDOI

Prolotherapy injections and eccentric loading exercises for painful Achilles tendinosis: a randomised trial

TL;DR: For Achilles tendinosis, prolotherapy and particularly ELE combined with prolotherapy give more rapid improvements in symptoms than ELE alone but long-term VISA-A scores are similar.